Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2007 Jun;66(6):842-3.
doi: 10.1136/ard.2006.066381.

Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

Clinical Trial

Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

George D Kalliolias et al. Ann Rheum Dis. 2007 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M. Adult Still's disease: review of 228 cases from the literature. J Rheumatol 1987141139–1146. - PubMed
    1. Dinarello C A. Blocking IL‐1 in systemic inflammation. J Exp Med 20052011355–1359. - PMC - PubMed
    1. Fitzgerald A A, LeClercq S A, Yan A, Homik J E, Dinarello C A. Rapid response to anakinra in patients with refractory adult‐onset Still's disease. Arthritis Rheum 2005521794–1803. - PubMed
    1. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H.et al Preliminary criteria for classification of adult Still's disease. J Rheumatol 199219424–430. - PubMed
    1. Fautrel B, Sibilia J, Mariette X, Combe B. Tumour necrosis factor α blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 200564262–266. - PMC - PubMed

Substances